检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:文希[1] 周光全[1] 黄斌芳 WEN Xi;ZHOU Guangquan;HUANG Binfang(Department of Endocrinology,Hanyang Hospital Affiliated to Wuhan University of Science and Technology/Hanyang Hospital,Wuhan Hubei 430000,China)
机构地区:[1]武汉科技大学附属汉阳医院/武汉市汉阳医院内分泌科,湖北武汉430000
出 处:《中国继续医学教育》2020年第12期131-133,共3页China Continuing Medical Education
摘 要:目的探讨长效胰岛素联合口服降糖药对2型糖尿病的治疗作用。方法选择本院100例2017年2月-2019年1月2型糖尿病患者。随机分组,长效胰岛素治疗组给予长效胰岛素治疗,长效胰岛素+口服降糖药沙格列汀组则实施长效胰岛素+口服降糖药沙格列汀治疗。比较两组2型糖尿病疗效;血糖达标的天数;治疗前后患者修整胰岛β细胞分泌指数、糖化血红蛋白、空腹、餐后血糖和血糖曲线下面积;低血糖率。结果长效胰岛素+口服降糖药沙格列汀组2型糖尿病疗效、血糖达标的天数、修整胰岛β细胞分泌指数、糖化血红蛋白、空腹、餐后血糖和血糖曲线下面积相比较长效胰岛素治疗组更好(P<0.05)。长效胰岛素+口服降糖药沙格列汀组低血糖率低于长效胰岛素治疗组(P<0.05)。结论长效胰岛素+口服降糖药沙格列汀治疗2型糖尿病效果确切,可获得理想效果,可更好改善血糖和胰岛功能,降低低血糖风险。Objective To investigate the therapeutic effect of long-acting insulin combined with oral hypoglycemic agents on type 2 diabetes. Methods 100 patients with type 2 diabetes from February 2017 to January 2019 in our hospital were selected. Randomly, long-acting insulin treatment group was given long-acting insulin therapy, long-acting insulin + oral hypoglycemic agent saxagliptin group was treated with long-acting insulin + oral hypoglycemic agent saxagliptin. The efficacy of type 2 diabetes was compared between the two groups;the number of days of blood glucose compliance;the percentage of islet β-cell secretion index, glycated hemoglobin, fasting, postprandial blood glucose and blood glucose curve.Results Long-acting insulin + oral hypoglycemic agent saxagliptin group 2 type of diabetes efficacy, days of blood glucose compliance, trimming isletβ cell secretion index, glycosylated hemoglobin, fasting, postprandial blood glucose and blood glucose curve area were better compared to longeracting insulin the treatment group, P<0.05. The long-acting insulin + oral hypoglycemic agent saxagliptin group had lower hypoglycemia rate than the long-acting insulin treatment group, P<0.05. Conclusion Long-acting insulin + oral hypoglycemic agent saxagliptin is effective in the treatment of type 2 diabetes and can achieve ideal results, which can better improve blood sugar and islet function and reduce the risk of hypoglycemia.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222